Skip to main content
logo
Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.020
+0.020 (2.00%)
At close: Oct 9, 2026, 4:00 PM EDT
1.074
+0.054 (5.29%)
After-hours: Oct 9, 2026, 7:16 PM EDT

Pliant Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-92.29-149.34-210.3-161.34-123.32-97.26
Depreciation & Amortization
1.311.72.131.841.821.54
Loss (Gain) From Sale of Assets
-0.14-0.04----
Loss (Gain) From Sale of Investments
0.923.962.51-4.99-1.811.26
Stock-Based Compensation
19.3826.2337.6344.4822.610.44
Other Operating Activities
5.155.113.452.391.861.67
Change in Accounts Receivable
---1.980.027.28
Change in Accounts Payable
0.15-5.481.432.97-1.350.89
Change in Other Net Operating Assets
-5.39-10.467.66-3.75.55-1.26
Operating Cash Flow
-70.9-128.34-155.5-116.36-94.63-75.44
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.37-3.85-0.92-1.76-1.95
Sale of Property, Plant & Equipment
0.270.16----
Investment in Securities
40.81134.51144.19-126.09-148.4475.65
Investing Cash Flow
41.08134.29140.34-127.01-150.273.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--19.91-9.85-
Long-Term Debt Repaid
--32.27----
Net Debt Issued (Repaid)
-32.27-32.2719.91-9.85-
Issuance of Common Stock
0.150.573.21275.25217.562.98
Other Financing Activities
----0.85-0.56-0.46
Financing Cash Flow
-32.12-31.723.12274.41226.852.53

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-61.94-25.747.9531.03-17.980.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-70.9-128.71-159.35-117.28-96.39-77.4
Free Cash Flow Growth
------
Free Cash Flow Margin
----7422.91%-995.26%-1022.13%
Free Cash Flow Per Share
-1.15-2.10-2.63-2.00-2.29-2.16
Levered Free Cash Flow
-42.51-84.56-98.53-66.86-51.12-42.56
Unlevered Free Cash Flow
-41.91-82.96-96.64-66.07-50.62-42.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.082.542.621.150.62-
Change in Working Capital
-5.24-15.949.091.254.226.92
SEC Filings: 10-K · 10-Q